1. Apoptosis Epigenetics Cell Cycle/DNA Damage Others
  2. MOFs Bcl-2 Family Caspase PARP Apoptosis Fluorescent Dye
  3. Chlorin e6

Chlorin e6 is a photosensitizer and has strong absorption peaks at wavelength of 402 and 662 nm, as well as exhibiting intense fluorescence at 668 nm. Chlorin e6 has antimicrobial efficacy and anticancer activity. Chlorin e6 induces cell apoptosis via caspase-3 activation and can be used for the research of cancer.

For research use only. We do not sell to patients.

Chlorin e6

Chlorin e6 Chemical Structure

CAS No. : 19660-77-6

Size Price Stock Quantity
Free Sample (0.1 - 0.2 mg)   Apply Now  
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO
ready for reconstitution
In-stock
Solution
10 mM * 1 mL in DMSO In-stock
Solid
50 mg In-stock
100 mg In-stock
200 mg   Get quote  
500 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 18 publication(s) in Google Scholar

Other Forms of Chlorin e6:

Top Publications Citing Use of Products
  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

Chlorin e6 is a photosensitizer and has strong absorption peaks at wavelength of 402 and 662 nm, as well as exhibiting intense fluorescence at 668 nm. Chlorin e6 has antimicrobial efficacy and anticancer activity. Chlorin e6 induces cell apoptosis via caspase-3 activation and can be used for the research of cancer[1][2][3].

Cellular Effect
Cell Line Type Value Description References
B16-F10 IC50
1.57 μM
Compound: Chlorin e6
Cytotoxicity against mouse B16-F10 cells incubated for 48 hrs under 10 J/cm2 light irradiation at 660 nm by CCK-8 assay
Cytotoxicity against mouse B16-F10 cells incubated for 48 hrs under 10 J/cm2 light irradiation at 660 nm by CCK-8 assay
[PMID: 37690263]
B16-F10 IC50
1.67 μM
Compound: Chlorin e6
Photodynamic antitumor activity against mouse B16-F10 cells assessed as inhibition of cell proliferation incubated for 48 hrs under 10 J/cm2 light irradiation at 660 nm by CCK-8 assay
Photodynamic antitumor activity against mouse B16-F10 cells assessed as inhibition of cell proliferation incubated for 48 hrs under 10 J/cm2 light irradiation at 660 nm by CCK-8 assay
[PMID: 37690263]
B16-F10 IC50
23.81 μM
Compound: Chlorin e6
Cytotoxicity against mouse B16-F10 cells incubated for 48 hrs under dark condition by CCK-8 assay
Cytotoxicity against mouse B16-F10 cells incubated for 48 hrs under dark condition by CCK-8 assay
[PMID: 37690263]
B16-F10 IC50
2305 nM
Compound: Ce6
Photodynamic cytotoxicity against mouse B16-F10 cells assessed as inhibition of cell viability incubated for 3 hrs followed by photo-irradiation at 54 J/cm2 measured after 24 hrs by CCK8 assay
Photodynamic cytotoxicity against mouse B16-F10 cells assessed as inhibition of cell viability incubated for 3 hrs followed by photo-irradiation at 54 J/cm2 measured after 24 hrs by CCK8 assay
[PMID: 37204432]
B16-F10 IC50
26.54 μM
Compound: Chlorin e6
Photodynamic antitumor activity against mouse B16-F10 cells assessed as inhibition of cell proliferation incubated for 48 hrs under dark condition by CCK-8 assay
Photodynamic antitumor activity against mouse B16-F10 cells assessed as inhibition of cell proliferation incubated for 48 hrs under dark condition by CCK-8 assay
[PMID: 37690263]
B16-F10 IC50
> 50 μM
Compound: Ce6
Cytotoxicity against mouse B16-F10 cells assessed as inhibition of cell viability under dark condition incubated for 27 hrs by CCK8 assay
Cytotoxicity against mouse B16-F10 cells assessed as inhibition of cell viability under dark condition incubated for 27 hrs by CCK8 assay
[PMID: 37204432]
HEp-2 IC50
20.8 μM
Compound: 5
Cytotoxicity against human Hep2 cells after overnight incubation followed by cells irradiated with 1 J/cm'2 light for 20 mins measured after overnight incubation by celltiter blue assay
Cytotoxicity against human Hep2 cells after overnight incubation followed by cells irradiated with 1 J/cm'2 light for 20 mins measured after overnight incubation by celltiter blue assay
[PMID: 21936519]
HEp-2 IC50
> 400 μM
Compound: 5
Cytotoxicity against human Hep2 cells under dark condition after 18 hrs by celltiter blue assay
Cytotoxicity against human Hep2 cells under dark condition after 18 hrs by celltiter blue assay
[PMID: 21936519]
HUVEC IC50
799.2 nM
Compound: Ce6
Photodynamic cytotoxicity against HUVEC cells assessed as inhibition of cell viability incubated for 3 hrs followed by photo-irradiation at 54 J/cm2 measured after 24 hrs by CCK8 assay
Photodynamic cytotoxicity against HUVEC cells assessed as inhibition of cell viability incubated for 3 hrs followed by photo-irradiation at 54 J/cm2 measured after 24 hrs by CCK8 assay
[PMID: 37204432]
HUVEC IC50
> 10 μM
Compound: 1
Antiproliferative activity against human HUVEC cells under 10 J/cm2 light irradiation at 660 nm by CCK8 assay
Antiproliferative activity against human HUVEC cells under 10 J/cm2 light irradiation at 660 nm by CCK8 assay
[PMID: 38118394]
HUVEC IC50
> 200 μM
Compound: 1
Antiproliferative activity against human HUVEC cells under dark condition by CCK8 assay
Antiproliferative activity against human HUVEC cells under dark condition by CCK8 assay
[PMID: 38118394]
HUVEC IC50
> 50 μM
Compound: Ce6
Cytotoxicity against HUVEC cells assessed as inhibition of cell viability under dark condition incubated for 27 hrs by CCK8 assay
Cytotoxicity against HUVEC cells assessed as inhibition of cell viability under dark condition incubated for 27 hrs by CCK8 assay
[PMID: 37204432]
HeLa IC50
1.92 μM
Compound: Ce6
Phototoxicity against human HeLa cells assessed as reduction in cell viability preincubated for 3 hrs followed by 54 J/cm2 light irradiation and measured after 24 hrs by MTT assay
Phototoxicity against human HeLa cells assessed as reduction in cell viability preincubated for 3 hrs followed by 54 J/cm2 light irradiation and measured after 24 hrs by MTT assay
[PMID: 32787080]
HeLa IC50
955 nM
Compound: Ce6
Photodynamic cytotoxicity against human HeLa cells assessed as inhibition of cell viability incubated for 3 hrs followed by photo-irradiation at 54 J/cm2 measured after 24 hrs by CCK8 assay
Photodynamic cytotoxicity against human HeLa cells assessed as inhibition of cell viability incubated for 3 hrs followed by photo-irradiation at 54 J/cm2 measured after 24 hrs by CCK8 assay
[PMID: 37204432]
HeLa IC50
955 nM
Compound: Ce6
Phototoxicity against human HeLa cells assessed as inhibition of cell viability preincubated for 3 hrs followed by photo-irradiation of 54 J/cm2 for 24 hrs by CCK8 assay
Phototoxicity against human HeLa cells assessed as inhibition of cell viability preincubated for 3 hrs followed by photo-irradiation of 54 J/cm2 for 24 hrs by CCK8 assay
[PMID: 39167079]
HeLa IC50
> 10 μM
Compound: 1
Antiproliferative activity against human HeLa cells under 10 J/cm2 light irradiation at 660 nm by CCK8 assay
Antiproliferative activity against human HeLa cells under 10 J/cm2 light irradiation at 660 nm by CCK8 assay
[PMID: 38118394]
HeLa IC50
> 100 μM
Compound: 1
Antiproliferative activity against human HeLa cells under dark condition by CCK8 assay
Antiproliferative activity against human HeLa cells under dark condition by CCK8 assay
[PMID: 38118394]
HeLa IC50
> 50 μM
Compound: Ce6
Dark toxicity in human HeLa cells assessed as reduction in cell viability after 3 hrs by MTT assay
Dark toxicity in human HeLa cells assessed as reduction in cell viability after 3 hrs by MTT assay
[PMID: 32787080]
HeLa IC50
> 50 μM
Compound: Ce6
Cytotoxicity against human HeLa cells assessed as inhibition of cell viability under dark condition incubated for 27 hrs by CCK8 assay
Cytotoxicity against human HeLa cells assessed as inhibition of cell viability under dark condition incubated for 27 hrs by CCK8 assay
[PMID: 37204432]
HeLa IC50
> 50 μM
Compound: Ce6
Dark cytotoxicity against human HeLa cells assessed as inhibition of cell viability incubated for 3 hrs by CCK8 assay
Dark cytotoxicity against human HeLa cells assessed as inhibition of cell viability incubated for 3 hrs by CCK8 assay
[PMID: 39167079]
HepG2 IC50
1.38 μM
Compound: Chlorin e6
Cytotoxicity against human HepG2 cells incubated for 48 hrs under 10 J/cm2 light irradiation at 660 nm by CCK-8 assay
Cytotoxicity against human HepG2 cells incubated for 48 hrs under 10 J/cm2 light irradiation at 660 nm by CCK-8 assay
[PMID: 37690263]
HepG2 IC50
1.66 μM
Compound: Chlorin e6
Photodynamic antitumor activity against human HepG2 cells assessed as inhibition of cell proliferation incubated for 48 hrs under 10 J/cm2 light irradiation at 660 nm by CCK-8 assay
Photodynamic antitumor activity against human HepG2 cells assessed as inhibition of cell proliferation incubated for 48 hrs under 10 J/cm2 light irradiation at 660 nm by CCK-8 assay
[PMID: 37690263]
HepG2 IC50
16 μM
Compound: 1
Antiproliferative activity against human HepG2 cells under 10 J/cm2 light irradiation at 660 nm by CCK8 assay
Antiproliferative activity against human HepG2 cells under 10 J/cm2 light irradiation at 660 nm by CCK8 assay
[PMID: 38118394]
HepG2 IC50
41.2 μM
Compound: Chlorin e6
Photo cytotoxic activity against human HepG2 cells irradiated with 1.7 J/cm'2 light dose for 10 mins measured after overnight incubation by MTT assay
Photo cytotoxic activity against human HepG2 cells irradiated with 1.7 J/cm'2 light dose for 10 mins measured after overnight incubation by MTT assay
[PMID: 26306981]
HepG2 IC50
41.53 μM
Compound: Chlorin e6
Photodynamic antitumor activity against human HepG2 cells assessed as inhibition of cell proliferation incubated for 48 hrs under dark condition by CCK-8 assay
Photodynamic antitumor activity against human HepG2 cells assessed as inhibition of cell proliferation incubated for 48 hrs under dark condition by CCK-8 assay
[PMID: 37690263]
HepG2 IC50
50.4 μM
Compound: Chlorin e6
Cytotoxicity against human HepG2 cells incubated for 48 hrs under dark condition by CCK-8 assay
Cytotoxicity against human HepG2 cells incubated for 48 hrs under dark condition by CCK-8 assay
[PMID: 37690263]
HepG2 IC50
52.9 μM
Compound: Chlorin e6
Dark toxicity in human HepG2 cells after overnight incubation by MTT assay
Dark toxicity in human HepG2 cells after overnight incubation by MTT assay
[PMID: 26306981]
HepG2 IC50
598.6 nM
Compound: Ce6
Photodynamic cytotoxicity against human HepG2 cells assessed as inhibition of cell viability incubated for 3 hrs followed by photo-irradiation at 54 J/cm2 measured after 24 hrs by CCK8 assay
Photodynamic cytotoxicity against human HepG2 cells assessed as inhibition of cell viability incubated for 3 hrs followed by photo-irradiation at 54 J/cm2 measured after 24 hrs by CCK8 assay
[PMID: 37204432]
HepG2 IC50
598.6 nM
Compound: Ce6
Phototoxicity against human HepG2 cells assessed as inhibition of cell viability preincubated for 3 hrs followed by photo-irradiation of 54 J/cm2 for 24 hrs by CCK8 assay
Phototoxicity against human HepG2 cells assessed as inhibition of cell viability preincubated for 3 hrs followed by photo-irradiation of 54 J/cm2 for 24 hrs by CCK8 assay
[PMID: 39167079]
HepG2 IC50
> 100 μM
Compound: 1
Antiproliferative activity against human HepG2 cells under dark condition by CCK8 assay
Antiproliferative activity against human HepG2 cells under dark condition by CCK8 assay
[PMID: 38118394]
HepG2 IC50
> 50 μM
Compound: Ce6
Cytotoxicity against human HepG2 cells assessed as inhibition of cell viability under dark condition incubated for 27 hrs by CCK8 assay
Cytotoxicity against human HepG2 cells assessed as inhibition of cell viability under dark condition incubated for 27 hrs by CCK8 assay
[PMID: 37204432]
HepG2 IC50
> 50 μM
Compound: Ce6
Dark cytotoxicity against human HepG2 cells assessed as inhibition of cell viability incubated for 3 hrs by CCK8 assay
Dark cytotoxicity against human HepG2 cells assessed as inhibition of cell viability incubated for 3 hrs by CCK8 assay
[PMID: 39167079]
Huh-7 IC50
18 μM
Compound: 1
Antiproliferative activity against human Huh-7 cells under 10 J/cm2 light irradiation at 660 nm by CCK8 assay
Antiproliferative activity against human Huh-7 cells under 10 J/cm2 light irradiation at 660 nm by CCK8 assay
[PMID: 38118394]
Huh-7 IC50
> 100 μM
Compound: 1
Antiproliferative activity against human Huh-7 cells under dark condition by CCK8 assay
Antiproliferative activity against human Huh-7 cells under dark condition by CCK8 assay
[PMID: 38118394]
MCF7 IC50
3.4 μM
Compound: Ce6
Phototoxicity against human MCF7 cells assessed as reduction in cell viability preincubated for 3 hrs followed by 54 J/cm2 light irradiation and measured after 24 hrs by MTT assay
Phototoxicity against human MCF7 cells assessed as reduction in cell viability preincubated for 3 hrs followed by 54 J/cm2 light irradiation and measured after 24 hrs by MTT assay
[PMID: 32787080]
MCF7 IC50
> 10 μM
Compound: 1
Antiproliferative activity against human MCF7 cells under 10 J/cm2 light irradiation at 660 nm by CCK8 assay
Antiproliferative activity against human MCF7 cells under 10 J/cm2 light irradiation at 660 nm by CCK8 assay
[PMID: 38118394]
MCF7 IC50
> 100 μM
Compound: 1
Antiproliferative activity against human MCF7 cells under dark condition by CCK8 assay
Antiproliferative activity against human MCF7 cells under dark condition by CCK8 assay
[PMID: 38118394]
MCF7 IC50
> 50 μM
Compound: Ce6
Dark toxicity in human MCF7 cells assessed as reduction in cell viability after 3 hrs by MTT assay
Dark toxicity in human MCF7 cells assessed as reduction in cell viability after 3 hrs by MTT assay
[PMID: 32787080]
SK-OV-3 IC50
0.39 μM
Compound: Chlorine E6
Photocytotoxicity in human SKOV3 cells assessed as cell death incubated for 6 hrs followed by PDT-1200 light irradiation at 20 J/cm2 measured after 16 hrs using liposome-encapsulated compound by MTT assay
Photocytotoxicity in human SKOV3 cells assessed as cell death incubated for 6 hrs followed by PDT-1200 light irradiation at 20 J/cm2 measured after 16 hrs using liposome-encapsulated compound by MTT assay
[PMID: 29670694]
SW480 IC50
3.1 μM
Compound: Ce6
Phototoxicity against human SW480 cells assessed as reduction in cell viability preincubated for 3 hrs followed by 54 J/cm2 light irradiation and measured after 24 hrs by MTT assay
Phototoxicity against human SW480 cells assessed as reduction in cell viability preincubated for 3 hrs followed by 54 J/cm2 light irradiation and measured after 24 hrs by MTT assay
[PMID: 32787080]
SW480 IC50
> 50 μM
Compound: Ce6
Dark toxicity in human SW480 cells assessed as reduction in cell viability after 3 hrs by MTT assay
Dark toxicity in human SW480 cells assessed as reduction in cell viability after 3 hrs by MTT assay
[PMID: 32787080]
In Vitro

Chlorin e6 (100 μg/mL, 24 h) with laser light (635 nm) exhibits no toxicity viability in HT-29 cells[2].
Chlorin e6 (5-10 μM, 3 h) with near-infrared laser light (660 nm) induces pancreatic cancer cell apoptosis via caspase-3 activation, resulting in tumor growth suppression in AsPC-1 and MIA PaCa-2 cells[3].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Western Blot Analysis[3]

Cell Line: AsPC-1 and MIA PaCa-2 Cells
Concentration: 5 μM, 10 μM
Incubation Time: 3 h
Result: Significantly reduced Bcl-2 protein expression while increasing apoptotic molecule expression of Bax.
Activated caspase-3 through its cleavage and upregulated the expression of cleaved PARP-1 in a dose-dependent manner.
In Vivo

Chlorin e6 (2.5 mg/kg, Intravenous injection, single dose) with a red light at a rate of 100 J/cm2 for 8 min 20 s has anti-tumor activity in B16F10 melanoma cells and PANC02 Pancreatic Cells xenograft mouse model[3].
Chlorin e6 (2.5 mg/kg, Intravenous injection, single dose) with near-infrared laser light (660 nm) suppresses the tumor growth in canine tumors[3].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: B16F10 melanoma cells xenograft mouse, PANC02 pancreatic cells xenograft mouse[3]
Dosage: 2.5 mg/kg
Administration: Intravenous injection (i.v.)
Result: Significantly reduced tumor volume.
Clinical Trial
Molecular Weight

596.67

Formula

C34H36N4O6

CAS No.
Appearance

Solid

Color

Brown to black

SMILES

OC(C/C1=C2[C@H]([C@@H](C(/C=C3N/C(C(C=C)=C\3C)=C\C4=N/C(C(CC)=C4C)=C\C5=C(C)C(C(O)=O)=C1N5)=N\2)C)CCC(O)=O)=O

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

-20°C, protect from light

*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

Solvent & Solubility
In Vitro: 

DMSO : 20 mg/mL (33.52 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 1.6760 mL 8.3798 mL 16.7597 mL
5 mM 0.3352 mL 1.6760 mL 3.3519 mL
View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

  • Molarity Calculator

  • Dilution Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass
=
Concentration
×
Volume
×
Molecular Weight *

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start)

C1

×
Volume (start)

V1

=
Concentration (final)

C2

×
Volume (final)

V2

In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

g

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Calculation results:
Working solution concentration: mg/mL
Purity & Documentation

Purity: 99.51%

References

Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
DMSO 1 mM 1.6760 mL 8.3798 mL 16.7597 mL 41.8992 mL
5 mM 0.3352 mL 1.6760 mL 3.3519 mL 8.3798 mL
10 mM 0.1676 mL 0.8380 mL 1.6760 mL 4.1899 mL
15 mM 0.1117 mL 0.5587 mL 1.1173 mL 2.7933 mL
20 mM 0.0838 mL 0.4190 mL 0.8380 mL 2.0950 mL
25 mM 0.0670 mL 0.3352 mL 0.6704 mL 1.6760 mL
30 mM 0.0559 mL 0.2793 mL 0.5587 mL 1.3966 mL
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Chlorin e6
Cat. No.:
HY-13594
Quantity:
MCE Japan Authorized Agent: